Pharmalink Healthcare

Naltivia 50 (Naltrexone Tablets 50 mg) is an opioid receptor antagonist used to support treatment of alcohol dependence and opioid addiction. It works by blocking the effects of opioids in the brain, reducing the risk of relapse, and diminishing alcohol cravings. The 50 mg tablet provides effective daily dosing to help maintain abstinence in patients undergoing addiction treatment programs. Naltivia 50 helps restore normal brain reward pathways, supporting behavioral therapy and recovery efforts. It is non-addictive and does not produce euphoria, making it safe for long-term use under medical supervision. The medication also aids in reducing relapse triggers and promoting sustained recovery. Regular use, combined with counseling and lifestyle support, enhances treatment outcomes and quality of life. Naltivia 50 is widely prescribed due to its efficacy, predictable effects, and safety profile. It is well-tolerated, though some patients may experience mild side effects such as nausea or headache. Proper adherence ensures optimal therapeutic benefit in addiction management. The tablet form is convenient for daily administration, supporting consistent treatment.